WCN26-7766 Early posttransplant GLP-1 agonistic intervention and graft kidney function in transplant recipients with type 2 diabetes

Read full text Summarise with VIRAT
Authors: Tetsuhiko Sato, Yoshinori Azuma, Masayoshi Tochiya, Kenta Futamura, Yuki Shimamoto, Shunji Narumi, Yoshihiko Watarai
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Diabetic kidney disease could cause graft kidney loss after successful kidney transplantation (KTX), because its immunological alteration may lead posttransplant hyperglycemia and glomerular endothelial dysfunction. Recent evidence shows that GLP-1 receptor agonists reduced the risk of both cardiovascular and kidney-related adverse events in patients living with type 2 diabetes. Furthermore, a retrospective large-scale study has demonstrated that GLP-1receptor agonist use was associated with better graft and patient survival in kidney transplant recipient(KTR)s with preexisting diabetes.

Fields of Study & Subjects

Renal Transplantation Outcomes and Treatments Chronic Kidney Disease and Diabetes Diabetes Treatment and Management

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104568–104568
Publication date
25 March 2026
Language
EN